FAQs

Each peptide batch is accompanied by a Certificate of Analysis (CoA) that summarizes tests, specifications, and results specific to that production batch. This documentation provides analytical properties but does not imply medicinal grade or sterility.

• CoAs are batch-specific and reviewed before being matched to stock.
• Redacted previews of CoAs are available on product pages and the Documentation Centre.
• Independent third-party analytical reports may also be available and are similarly displayed.

Understanding how to read these certificates is crucial; our guide How to Read a Certificate of Analysis offers detailed insights.

Citation: https://purepeps.uk/policies/research-use#7

We review all batch documentation for internal consistency and only publish it once it has been matched to the applicable vial stock. Documentation that cannot be reconciled with physical stock is withheld from publication.

• This ensures that customers see accurate, verified information.
• The process includes checking batch numbers and analytical data.
• Documentation includes Certificates of Analysis and any third-party testing reports.

This quality assurance step is detailed in our Research Use Policy.

Citation: https://purepeps.uk/policies/research-use#9

Peptide purity information is provided based on chromatographic purity, chemical identity, and peptide content, but these are distinct measurements. We supply Certificates of Analysis that include chromatographic purity data, typically from HPLC methods, alongside complementary identity testing such as LC-MS.

• Purity percentages reflect relative signal under specific chromatographic conditions.
• Purity data must be interpreted alongside identity and assay results.
• Our Understanding HPLC Peptide Purity Testing article explains this in detail.

Citation: https://purepeps.uk/research/foundations/what-are-research-peptides

On each product page, look for the batch or lot number displayed alongside the peptide details. This identifier confirms the specific batch in stock and links to the batch documentation in the Documentation Centre.

• Batch numbers are essential for traceability and quality control.
• Documentation linked to the batch includes Certificates of Analysis and any third-party reports.
• This ensures you receive the exact peptide batch described.

For a comprehensive overview, visit the Documentation Centre and related product pages.

Citation: https://purepeps.uk/policies/research-use#6

You can confirm live stock availability by checking the product page where each stocked batch is identified by a batch or lot number. We display batch identifiers only when batch documentation has been received and reconciled with the stock, ensuring the peptide is available for immediate dispatch.

• Batch numbers are shown on the product page and in the Documentation Centre.
• Documentation must match the physical stock before publication.
• This process helps maintain transparency about what is currently available.

For more details on batch traceability and documentation, see our Research Use Policy and the Growth Hormone Research category.

Citation: https://purepeps.uk/policies/research-use#6

Our documentation reflects information provided by manufacturers about peptide synthesis, including solid-phase peptide synthesis (SPPS) methods and impurity profiles. Certificates of Analysis may report impurities such as truncated sequences, epimerised residues, or oxidised variants.

• We include details on manufacturing processes when available.
• Impurity profiles help you assess peptide suitability for your experiments.
• The EMA recommends using at least two orthogonal methods for identity confirmation, which we support through documentation.

Learn more about peptide manufacturing and impurities in our Foundations article.

Citation: https://purepeps.uk/research/foundations/what-are-research-peptides

Independent third-party laboratory testing reports, when available, are displayed as redacted previews on the corresponding product pages and in the Documentation Centre. If no independent testing is currently available for a batch, the documentation status is marked as pending.

• This transparency helps you assess peptide quality beyond manufacturer data.
• Pending status indicates ongoing efforts to obtain independent verification.
• You can compare these reports alongside Certificates of Analysis for a comprehensive view.

See the Research Use Policy for more information on independent testing.

Citation: https://purepeps.uk/policies/research-use#8

While our documentation provides detailed analytical data such as identity, purity, and content, it does not guarantee suitability for any particular experiment or regulatory status. You should interpret Certificates of Analysis alongside your experimental requirements and consider complementary testing.

• Documentation confirms chemical identity and purity but not sterility or endotoxin status.
• You remain responsible for ensuring compliance with local regulations and suitability.
• Our Research Use Policy outlines intended uses and customer responsibilities.

Citation: https://purepeps.uk/research/foundations/what-are-research-peptides

Documentation status on product pages reflects whether batch-specific Certificates of Analysis and independent laboratory reports have been received, reviewed, and matched to stock.

• "Available" means documentation is published and linked to the batch.
• "Pending" indicates documentation is awaited or under review.
• Documentation previews are redacted to protect proprietary information but provide key analytical data.

This system helps you quickly assess the transparency and quality assurance level for each peptide batch.

More details are available in our Research Use Policy.

Citation: https://purepeps.uk/policies/research-use#7

If a peptide batch lacks complete documentation or is not currently in stock, it will not be listed with batch identifiers or documentation previews. The Documentation Centre will mark such documentation as pending, and the product page will reflect the absence of verified stock.

• This prevents customers from ordering unverified or unavailable materials.
• We only publish documentation that has been matched to physical stock.
• Transparency about availability and documentation status is a priority.

Refer to our Research Use Policy for details on quality assurance and stock management.

Citation: https://purepeps.uk/policies/research-use#9